MG
Meditor Group Portfolio holdings
AUM
$48.1M
This Quarter Return
-17.26%
1 Year Return
+38.67%
3 Year Return
+41.15%
5 Year Return
+72.2%
10 Year Return
+1,065.64%
AUM
$411M
AUM Growth
+$411M
(-17%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 93.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Exelixis
EXEL
$10.1B
| $265M | 64.62% | 15,001,073 | – | – |
|
2
Esperion Therapeutics
ESPR
$448M
| $98.2M | 23.93% | 2,679,835 | – | – |
|
3
Alkermes
ALKS
$4.78B
| $17.4M | 4.24% | 892,400 | – | – |
|
4
iShares MSCI India ETF
INDA
$9.17B
| $10.7M | 2.62% | 320,000 | – | – |
|
5
WisdomTree India Earnings Fund ETF
EPI
$2.86B
| $9.54M | 2.32% | 400,000 | – | – |
|
6
ProShares UltraShort S&P500
SDS
$445M
| $3.39M | 0.83% | 115,000 | – | – |
|
7
ProShares UltraPro Short S&P 500
SPXU
$527M
| $2.73M | 0.66% | 105,000 | – | – |
|
8
ProShares UltraPro Short QQQ
SQQQ
$2.39B
| $2.32M | 0.56% | 71,250 | – | – |
|
9
Celldex Therapeutics
CLDX
$1.47B
| $896K | 0.22% | 420,846 | – | – |
|